Federal appeals court to consider Louisiana’s arguments for banning telehealth abortion
The case could affect telehealth access nationwide, with about 91,000 abortions last year linked to mail prescriptions in ban states, Guttmacher Institute said.
- On Wednesday, the U.S. Fifth Circuit Court of Appeals will hear arguments regarding Louisiana's challenge to telehealth abortion access, seeking to overturn federal rules permitting abortion pills prescribed without in-person visits.
- Louisiana officials argue the 2023 Food and Drug Administration rule allowing mail-order abortion pills violates the 2022 Supreme Court ruling in Dobbs v. Jackson Women's Health Organization, which returned abortion regulation to states.
- According to Guttmacher Institute, about 91,000 abortions were provided last year via telehealth prescriptions, including more than 9,300 in Louisiana; Alliance Defending Freedom counsel Gabriella McIntyre expects a favorable ruling.
- Abortion law expert Mary Ziegler expects the conservative Fifth Circuit to side with Louisiana, noting the ruling will likely serve as a roadmap for the U.S. Supreme Court's future deliberations.
- Pressure from anti-abortion policymakers continues as the FDA conducts a safety review of mifepristone as part of broader efforts to restrict access nationwide.
184 Articles
184 Articles
Ring The Alarm! The Right To TeleHealth For Abortion May Be Over [Op-Ed]
I am not saying abortion access is like enslavement (though there is the thread of bodily autonomy running through both), but this reminds me of the Dred Scott v. Sandford (1857) decision.
U.S. appeals court hears Louisiana abortion pill case that could limit access nationwide
Attorney General Liz Murrill asked an appeals court Wednesday to strike down a federal government policy allowing abortion pills to be mailed over state lines, saying the regulation has snarled enforcement of Louisiana’s anti-abortion laws in a case that could shape access to the procedure nationwide.
Federal Appeals Court hears arguments in Louisiana on abortion pill
The fight over access to abortion pills by mail and through pharmacies continues. The Fifth Circuit Court of Appeals heard arguments from Attorney General Liz Murrill and the FDA over mifepristone restrictions in Louisiana.
An appeals court is considering a push to restrict most common abortion method: mifepristone
A panel of federal judges heard arguments Wednesday over whether prescribing rules should be tightened for a key drug used in the most common abortion method in the United States: mifepristone.
Coverage Details
Bias Distribution
- 49% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
























![[your]NEWS](/_next/image?url=https%3A%2F%2Fgroundnews.b-cdn.net%2Finterests%2Ffb6dc495f74049f513563c33352175eaa0ecd509.jpg%3Fwidth%3D60&w=128&q=75)













